Abstract
Summary
KEY FINDINGS
The China digital transformation in healthcare market is expected to evolve with a CAGR of 31.93%, during the forecast years. The country’s market growth is supplemented by key drivers, such as, the rising adoption of digitization within the healthcare sector and the challenges faced amid the COVID-19 pandemic. The base year considered for the market study is 2020, and the forecast period is from 2021 to 2026.
MARKET INSIGHTS
China aims to progress towards efficient digital transformation within the country’s healthcare sector. For instance, in January 2020, Beijing Keya Medical announced that its imaging solution in cardiac management was approved by the CFDA, as China’s first artificial intelligence (AI) medical device. The device, DEEPVESSEL FFR, non-invasively detects ischemia in patients with suspected coronary artery disease, before advising further invasive coronary angiography. Moreover, it also enables cardiologists to make better treatment decisions, while helping patients avoid potential complications and discomfort, due to unnecessary surgical procedures and invasive examinations.
However, the lack of a consistently implemented and widely adopted medical terminology system is a significant problem, in terms of using big data in medical research. Widely accepted terminology systems, including, the Unified Medical Language System (UMLS), the Systematized Nomenclature of Medicine–Clinical Terms (SNOMED CT), and the General Architecture for Languages, Encyclopedias, and Nomenclatures in Medicine (GALEN), are unavailable in China. This is primarily accredited to the linguistic differences between English and Chinese, thereby inhibiting the healthcare sector’s growth. As a result, these factors are anticipated to influence the digital transformation in healthcare market growth in China, over the studied period.
COMPETITIVE INSIGHTS
Some of the main players operating in the market are, Microsoft Corporation, Apple Inc, International Business Machines Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
1 RESEARCH SCOPE & METHODOLOGY
1.1 STUDY OBJECTIVES
1.2 SCOPE OF STUDY
1.3 METHODOLOGY
1.4 ASSUMPTIONS & LIMITATIONS
2 EXECUTIVE SUMMARY
2.1 MARKET SIZE & ESTIMATES
2.2 COUNTRY SNAPSHOT
2.3 COUNTRY ANALYSIS
2.4 KEY GROWTH ENABLERS
2.5 KEY CHALLENGES
3 KEY ANALYTICS
3.1 IMPACT OF COVID-19 ON CHINA DIGITAL TRANSFORMATION IN HEALTHCARE MARKET
3.2 KEY INVESTMENT INSIGHTS
3.3 PORTER’S FIVE FORCES ANALYSIS
3.3.1 BUYERS POWER
3.3.2 SUPPLIERS POWER
3.3.3 SUBSTITUTION
3.3.4 NEW ENTRANTS
3.3.5 INDUSTRY RIVALRY
3.4 OPPORTUNITY MATRIX
3.5 KEY BUYING CRITERIA
3.5.1 COST
3.5.2 DATA SHARING FEATURES
3.5.3 INTEROPERABILITY
4 MARKET BY TYPE
4.1 PRODUCT
4.2 SERVICE
5 MARKET BY TECHNOLOGY
5.1 ARTIFICIAL INTELLIGENCE
5.2 BIG DATA
5.3 BLOCKCHAIN
5.4 AUGMENTED REALITY/ VIRTUAL REALITY
5.5 INTERNET OF MEDICAL THINGS
5.6 MHEALTH
5.7 TELEHEALTH
5.8 ROBOTICS
6 MARKET BY FUNCTION
6.1 CUSTOMER TRANSFORMATION
6.2 WORKFORCE TRANSFORMATION
6.3 OPERATIONAL TRANSFORMATION
6.4 PRODUCT TRANSFORMATION
7 MARKET BY DEPLOYMENT MODE
7.1 CLOUD
7.2 ON PREMISE
8 MARKET BY END-USE
8.1 HEALTHCARE
8.1.1 PAYER
8.1.2 PROVIDER
8.1.3 HOMECARE
8.2 LIFE SCIENCES
8.3 OTHER END-USERS
9 COMPETITIVE LANDSCAPE
9.1 KEY STRATEGIC DEVELOPMENTS
9.1.1 MERGERS & ACQUISITIONS
9.1.2 PARTNERSHIPS & AGREEMENTS
9.1.3 BUSINESS EXPANSIONS/DIVESTITURES
9.2 COMPANY PROFILES
9.2.1 ALIBABA
9.2.2 BAIDU
9.2.3 HUIYING MEDICAL TECHNOLOGY CO LTD
9.2.4 INFERVISION
9.2.5 TENCENT